GlassScriptPhysician profile
Justin L Okray
NPI 1639572902
$5,242.28
in general payments reported to CMS, 2019-2025
15 companies · $505 in 2025
The $505 reported for 2025 was more than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $321 · 2022: $918 · 2023: $2,657 · 2024: $840 · 2025: $505.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,138 · Travel and Lodging: $834 · Entertainment: $30.15.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,138.16 |
| Travel and Lodging | $834.43 |
| Entertainment | $30.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $3,233.00 | 2021-2025 | Thoratec Heartmate 3 Lvas Implant Kit, Heartmate Touch |
| Abiomed | $1,012.02 | 2023-2025 | Impella |
| Medtronic, INC. | $336.52 | 2021-2025 | Hvad Pump Implant Kit |
| Amgen INC. | $139.85 | 2022 | |
| Cvrx, INC. | $134.92 | 2023 | Barostim Neo System |
| Astrazeneca Pharmaceuticals LP | $123.99 | 2022-2025 | Farxiga, Wainua, Brilinta |
| Boston Scientific Corporation | $55.70 | 2023 | Watchman Access System |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $36.57 | 2023-2024 | Lifevest |
| Lexicon Pharmaceuticals, INC. | $32.30 | 2023 | Inpefa |
| Argentum Medical | $30.15 | 2025 | |
| Pfizer INC. | $27.27 | 2023 | |
| Takeda Pharmaceuticals U.S.A., INC. | $23.33 | 2023 | Livtencity |
| Edwards Lifesciences Corporation | $21.62 | 2024 | Mitris Resilia Mitral Valve |
| Lemaitre Vascular, INC. | $20.26 | 2023 | Restoreflow |
| Merck Sharp & Dohme LLC | $14.78 | 2023 | Verquvo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Justin Okray listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.